Emergent BioSolutions Inc.’s Q3 2026 10-Q window runs Oct 28, 2026 to Nov 10, 2026.
Based on 8 prior 10-Q filings.
Emergent BioSolutions Inc. · CIK 1367644 · Engraved from SEC EDGAR